197 related articles for article (PubMed ID: 35186021)
1. Clinical and Biological Significance of DNA Methylation-Driven Differentially Expressed Genes in Biochemical Recurrence After Radical Prostatectomy.
Luo C; He S; Zhang H; He S; Qi H; Wei A
Front Genet; 2022; 13():727307. PubMed ID: 35186021
[No Abstract] [Full Text] [Related]
2. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
3. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer.
Lv D; Cao Z; Li W; Zheng H; Wu X; Liu Y; Gu D; Zeng G
Front Surg; 2021; 8():665115. PubMed ID: 34136527
[No Abstract] [Full Text] [Related]
4. A Three-Gene Classifier Associated With MicroRNA-Mediated Regulation Predicts Prostate Cancer Recurrence After Radical Prostatectomy.
Cheng B; He Q; Cheng Y; Yang H; Pei L; Deng Q; Long H; Zhu L; Jiang R
Front Genet; 2019; 10():1402. PubMed ID: 32117427
[TBL] [Abstract][Full Text] [Related]
5. A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy.
Zhang Q; Zhao K; Song L; Ji C; Cong R; Luan J; Zhou X; Xia J; Song N
Front Genet; 2020; 11():586376. PubMed ID: 33329725
[No Abstract] [Full Text] [Related]
6. Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.
Luan J; Zhang Q; Song L; Wang Y; Ji C; Cong R; Zheng Q; Xu Z; Xia J; Song N
Transl Androl Urol; 2021 Mar; 10(3):1018-1029. PubMed ID: 33850736
[TBL] [Abstract][Full Text] [Related]
7. A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7.
Wu X; Lv D; Lei M; Cai C; Zhao Z; Eftekhar M; Gu D; Liu Y
Oncol Lett; 2020 Sep; 20(3):2906-2918. PubMed ID: 32782607
[TBL] [Abstract][Full Text] [Related]
8. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
[TBL] [Abstract][Full Text] [Related]
9. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
Zhao Y; Tao Z; Li L; Zheng J; Chen X
BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
[TBL] [Abstract][Full Text] [Related]
10. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer.
Deng GC; Sun DC; Zhou Q; Lv Y; Yan H; Han QL; Dai GH
BMC Genomics; 2021 Nov; 22(1):791. PubMed ID: 34732125
[TBL] [Abstract][Full Text] [Related]
11. Identification of a prognostic biomarker predicting biochemical recurrence and construction of a novel nomogram for prostate cancer.
Yu Z; Chao H; Xu F; Deng H; Deng L; Song Z; Zeng T
Front Oncol; 2023; 13():1115718. PubMed ID: 37077837
[TBL] [Abstract][Full Text] [Related]
12. Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer.
Long G; Ouyang W; Zhang Y; Sun G; Gan J; Hu Z; Li H
Front Mol Biosci; 2021; 8():608369. PubMed ID: 33778002
[No Abstract] [Full Text] [Related]
13. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
15. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
16. Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer.
Song G; Zhang Y; Li H; Liu Z; Song W; Li R; Wei C; Wang T; Liu J; Liu X
Front Genet; 2021; 12():778503. PubMed ID: 35111198
[No Abstract] [Full Text] [Related]
17. A new risk stratification system of prostate cancer to identify high-risk biochemical recurrence patients.
Wu X; Lv D; Eftekhar M; Khan A; Cai C; Zhao Z; Gu D; Liu Y
Transl Androl Urol; 2020 Dec; 9(6):2572-2586. PubMed ID: 33457230
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of DNA Methylation Identified 12 Signature Genes Specific to Metastatic ccRCC.
Qian S; Sun S; Zhang L; Tian S; Xu K; Zhang G; Chen M
Front Oncol; 2020; 10():556018. PubMed ID: 33134164
[No Abstract] [Full Text] [Related]
19. ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer.
Zhang W; Shu P; Wang S; Song J; Liu K; Wang C; Ran L
Gene; 2018 Oct; 675():136-143. PubMed ID: 29966681
[TBL] [Abstract][Full Text] [Related]
20. Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.
Brockman JA; Alanee S; Vickers AJ; Scardino PT; Wood DP; Kibel AS; Lin DW; Bianco FJ; Rabah DM; Klein EA; Ciezki JP; Gao T; Kattan MW; Stephenson AJ
Eur Urol; 2015 Jun; 67(6):1160-1167. PubMed ID: 25301759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]